D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 48 Citations 7,686 122 World Ranking 3598 National Ranking 122

Overview

What is she best known for?

The fields of study she is best known for:

  • Bacteria
  • Antibiotics
  • Gene

Her primary areas of investigation include Microbiology, Escherichia coli, Nalidixic acid, Tetracycline and Enterobacteriaceae. Her Microbiology research is multidisciplinary, incorporating perspectives in Bacterial genetics, Cefoxitin and Bacteria. The Escherichia coli study combines topics in areas such as Antibacterial agent, Sequence analysis and Polymerase chain reaction.

Her study explores the link between Nalidixic acid and topics such as Amikacin that cross with problems in Campylobacter jejuni, Campylobacter, Broiler, Campylobacter coli and Gentamicin. Her Tetracycline study combines topics from a wide range of disciplines, such as Norfloxacin, Enterobacter aerogenes, Acinetobacter, Efflux and Chloramphenicol. Her Enterobacteriaceae research incorporates elements of Agar plate and Agar diffusion test.

Her most cited work include:

  • Mechanisms of Resistance in Multiple-Antibiotic-Resistant Escherichia coli Strains of Human, Animal, and Food Origins (326 citations)
  • Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. (269 citations)
  • β-Lactamases in Ampicillin-Resistant Escherichia coli Isolates from Foods, Humans, and Healthy Animals (232 citations)

What are the main themes of her work throughout her whole career to date?

Yolanda Sáenz focuses on Microbiology, Escherichia coli, Gene, Genetics and Antibiotic resistance. Specifically, her work in Microbiology is concerned with the study of Integron. The various areas that Yolanda Sáenz examines in her Escherichia coli study include Antibacterial agent, Sequence analysis and Polymerase chain reaction.

Her Antibiotic resistance study incorporates themes from Acinetobacter haemolyticus, Acinetobacter, Serotype and Drug resistance. Her work carried out in the field of Drug resistance brings together such families of science as Tetracycline and Food microbiology. Her Enterobacteriaceae study combines topics in areas such as Molecular genetics, Molecular epidemiology, Beta-lactamase and Bacteria.

She most often published in these fields:

  • Microbiology (85.71%)
  • Escherichia coli (29.37%)
  • Gene (24.60%)

What were the highlights of her more recent work (between 2018-2021)?

  • Microbiology (85.71%)
  • Pseudomonas aeruginosa (16.67%)
  • Antibiotic resistance (20.63%)

In recent papers she was focusing on the following fields of study:

Microbiology, Pseudomonas aeruginosa, Antibiotic resistance, Biofilm and Virulence are her primary areas of study. Her study brings together the fields of Enterobacteriaceae and Microbiology. Yolanda Sáenz studied Pseudomonas aeruginosa and Antimicrobial that intersect with Raw milk, Gene, Gentamicin, Cefepime and Ciprofloxacin.

Her Antibiotic resistance research is multidisciplinary, relying on both Acinetobacter haemolyticus and Acinetobacter. Yolanda Sáenz works mostly in the field of Biofilm, limiting it down to topics relating to Food contact and, in certain cases, Bacterial colonization. She combines subjects such as Antibiotics, Pseudomonas mendocina, Multilocus sequence typing and Pulsed-field gel electrophoresis with her study of Virulence.

Between 2018 and 2021, her most popular works were:

  • Pseudomonas aeruginosa Utilizes Host-Derived Itaconate to Redirect Its Metabolism to Promote Biofilm Formation. (22 citations)
  • CFTR-PTEN-dependent mitochondrial metabolic dysfunction promotes Pseudomonas aeruginosa airway infection. (21 citations)
  • Production of Antibacterial Coatings Through Atmospheric Pressure Plasma: a Promising Alternative for Combatting Biofilms in the Food Industry (11 citations)

In her most recent research, the most cited papers focused on:

  • Bacteria
  • Antibiotics
  • Gene

Yolanda Sáenz mostly deals with Microbiology, Antibiotic resistance, Pseudomonas aeruginosa, Biofilm and Acinetobacter haemolyticus. She has researched Microbiology in several fields, including Virulence factor, High prevalence and Pseudomonas. The concepts of her Antibiotic resistance study are interwoven with issues in Serotype, Genotype, Pulsed-field gel electrophoresis, Drug resistance and Virulence.

Her work deals with themes such as Reactive oxygen species, Cell biology and Cystic fibrosis, which intersect with Pseudomonas aeruginosa. Her studies deal with areas such as Inflammation, Lipopolysaccharide, Downregulation and upregulation and Immune system as well as Biofilm. Her research is interdisciplinary, bridging the disciplines of Plasmid and Acinetobacter haemolyticus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Mechanisms of Resistance in Multiple-Antibiotic-Resistant Escherichia coli Strains of Human, Animal, and Food Origins

Yolanda Sáenz;Laura Briñas;Elena Domínguez;Joaquim Ruiz.
Antimicrobial Agents and Chemotherapy (2004)

530 Citations

Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998.

Y. Sáenz;M. Zarazaga;M. Lantero;M. J. Gastañares.
Antimicrobial Agents and Chemotherapy (2000)

418 Citations

β-Lactamases in Ampicillin-Resistant Escherichia coli Isolates from Foods, Humans, and Healthy Animals

Laura Briñas;Myriam Zarazaga;Yolanda Sáenz;Fernanda Ruiz-Larrea.
Antimicrobial Agents and Chemotherapy (2002)

371 Citations

Detection of Escherichia coli harbouring extended-spectrum β-lactamases of the CTX-M, TEM and SHV classes in faecal samples of wild animals in Portugal

Daniela Costa;Daniela Costa;Patricia Poeta;Yolanda Sáenz;Laura Vinué.
Journal of Antimicrobial Chemotherapy (2006)

238 Citations

Detection of CMY-2, CTX-M-14, and SHV-12 β-Lactamases in Escherichia coli Fecal-Sample Isolates from Healthy Chickens

Laura Briñas;Miguel Angel Moreno;Myriam Zarazaga;Concepción Porrero.
Antimicrobial Agents and Chemotherapy (2003)

237 Citations

Antibiotic resistance in Escherichia coli isolates obtained from animals, foods and humans in Spain

Yolanda Sáenz;Myriam Zarazaga;Laura Briñas;Marta Lantero.
International Journal of Antimicrobial Agents (2001)

233 Citations

Characterization of CTX-M and SHV extended-spectrum β-lactamases and associated resistance genes in Escherichia coli strains of food samples in Tunisia

Ahlem Jouini;Laura Vinué;Karim Ben Slama;Yolanda Sáenz.
Journal of Antimicrobial Chemotherapy (2007)

228 Citations

Assessment of antibiotic susceptibility within lactic acid bacteria strains isolated from wine

Beatriz Rojo-Bezares;Yolanda Sáenz;Patricia Poeta;Myriam Zarazaga.
International Journal of Food Microbiology (2006)

188 Citations

Monitoring and Characterization of Extended-Spectrum β-Lactamases in Escherichia coli Strains from Healthy and Sick Animals in Spain in 2003

Laura Briñas;Miguel Angel Moreno;Tirushet Teshager;Yolanda Sáenz.
Antimicrobial Agents and Chemotherapy (2005)

180 Citations

Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolates in faecal samples of broilers.

Daniela Costa;Laura Vinué;Patricia Poeta;Ana Cláudia Coelho.
Veterinary Microbiology (2009)

178 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Yolanda Sáenz

Carmen Torres

Carmen Torres

University of La Rioja

Publications: 153

Joaquim Ruiz

Joaquim Ruiz

Scientific University of the South

Publications: 27

Myriam Zarazaga

Myriam Zarazaga

University of La Rioja

Publications: 27

Dik Mevius

Dik Mevius

Utrecht University

Publications: 25

Luísa Peixe

Luísa Peixe

University of Porto

Publications: 21

Yang Wang

Yang Wang

China Agricultural University

Publications: 21

Kristina Kadlec

Kristina Kadlec

Friedrich-Loeffler-Institut

Publications: 20

Frank Møller Aarestrup

Frank Møller Aarestrup

Technical University of Denmark

Publications: 20

Lothar H. Wieler

Lothar H. Wieler

Robert Koch Institute

Publications: 19

Laurent Poirel

Laurent Poirel

University of Fribourg

Publications: 18

Jaap A. Wagenaar

Jaap A. Wagenaar

Utrecht University

Publications: 18

Patrick F. McDermott

Patrick F. McDermott

US Food and Drug Administration

Publications: 17

Alessandra Carattoli

Alessandra Carattoli

Sapienza University of Rome

Publications: 17

Richard J. Reid-Smith

Richard J. Reid-Smith

Public Health Agency of Canada

Publications: 17

Antonio Gálvez

Antonio Gálvez

University of Jaén

Publications: 16

Rafael Cantón

Rafael Cantón

Instituto Ramón y Cajal de Investigación Sanitaria

Publications: 15

Trending Scientists

Michael O'Neill

Michael O'Neill

University College Dublin

Manlio Del Giudice

Manlio Del Giudice

Link Campus University

Dulal Pal

Dulal Pal

Visva-Bharati University

Marco Peccianti

Marco Peccianti

University of Sussex

W. Z. Hassid

W. Z. Hassid

University of California, Berkeley

Gregory B. Olson

Gregory B. Olson

Northwestern University

Grigori Enikolopov

Grigori Enikolopov

Stony Brook University

Earl G. Brown

Earl G. Brown

University of Ottawa

Carol J. Ptacek

Carol J. Ptacek

University of Waterloo

Karl K. Turekian

Karl K. Turekian

Yale University

Song Guo

Song Guo

Peking University

Eddie A. James

Eddie A. James

Virginia Mason Medical Center

Jean-Louis Teboul

Jean-Louis Teboul

University of Paris-Saclay

Paolo Pelosi

Paolo Pelosi

University of Genoa

Mary Jane Esplen

Mary Jane Esplen

University of Toronto

Robert Miles

Robert Miles

University of Glasgow

Something went wrong. Please try again later.